According to VYNE Therapeutics's latest financial reports the company's current earnings (TTM) are -S$40.18 M. In 2023 the company made an earning of -S$38.12 M an increase over its 2022 earnings that were of -S$44.37 M.The earnings displayed on this page is the company's Pretax Income.